Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fotmer Life Sciences
Uruguay
- Ownership
- Private
- Employees
- ~245
- Development stage
- Other
01
Overview
Fotmer Life Sciences is a leading global cultivator and exporter of medical cannabis, producing and distributing standardized cannabis extracts and products for pharmaceutical and medical use. The company operates under strict GACP and Uruguayan-GMP certification, supplies international markets, and emphasizes quality control, traceability, and in-house R&D. It does not publicly disclose detailed clinical trial results or specific product outcomes, nor does it describe specific pipeline candidates, clinical trials, or regulatory milestones.
- Therapeutic areas
- Neurology
- Modalities
- Cannabis extractSmall molecule
- Industry
- Agriculture & AgTech
Beyond the preview
Go deeper on Fotmer Life Sciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fotmer Life Sciences.